Host: David M. Simpson, MD

Guest: David R. Walega, MD

Guest: Eric J. Viel, MD, PhD

Find the full Prescribing Information here.

What are some of the current challenges in treating patients with painful diabetic peripheral neuropathy, and how can we overcome them? Explore those questions and more through the lens of patient case studies with Dr David M. Simpson, Dr Eric Viel, and Dr David Walega.

Here to walk us through the clinical trial data that led to the FDA approval of a treatment option for painful diabetic peripheral neuropathy of the feet is Dr David M. Simpson, a Professor of Neurology at the Icahn School of Medicine and Director of the Clinical Neurophysiology Laboratories and Neuromuscular Division at Mount Sinai in New York.

QUTENZA® is a registered trademark of Averitas Pharma, Inc.
© 2021 Averitas Pharma, Inc. All rights reserved.
M-QZA-US-01-21-0060 July 2021